Therefore, we hypothesized that the combined use of ELTN and FDTN could enhance the cytotoxicity of ELTN and inhibit the growth of ELTN-resistant NSCLC cells via suppression of the JAK2/STAT3 signaling pathway. Here, JAK2 is linked to non-small cell lung carcinoma.